Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Other Accumulated Expenses (2021 - 2022)

Actinium Pharmaceuticals (ATNM) has disclosed Other Accumulated Expenses for 2 consecutive years, with $934000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Other Accumulated Expenses rose 92.18% to $934000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $934000.0, a 92.18% increase, with the full-year FY2022 number at $934000.0, up 92.18% from a year prior.
  • Other Accumulated Expenses was $934000.0 for Q4 2022 at Actinium Pharmaceuticals, up from $91000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $934000.0 in Q4 2022 to a low of $91000.0 in Q3 2022.